Novartis has a strong heritage and works in partnership with the NHS to improve the delivery and efficiency of healthcare to achieve improved patient experiences and outcomes.
We do this through a range of innovative transformation programmes, including joint working projects (JWPs), outcomes based models (OBCMs), pathway re-design and others – our partnerships span multiple therapeutic areas where we have rich heritage and expertise.
Novartis works closely with NHS trusts and the wider healthcare system to evidence new ways of working in delivering patient care that makes the case for sustainable change for the long term by demonstrating improved efficiencies and better patient outcomes.
When a pharmaceutical company works in partnership with the NHS, this is normally known as ‘joint working’; where both the company and the NHS contribute financially, provide skills, knowledge and other resources.
Novartis has been involved in over 140 joint working initiatives across the UK since 2011. We’re proud to invest around seven times the industry average each year and believe joint working is vital to help NHS Trusts adopt sustainable models of care that deliver tangible benefits to patients
Joint working initiatives can re-shape, improve and optimise patient care. When Novartis embarks on a joint working project with the NHS, our common goal is to improve patient outcomes by working together, and Novartis is guided by our commitment to patients, our pledge to patients worldwide. It outlines what patients can expect from us, including a commitment to acting with integrity, providing them access to innovative, high quality medicines and incorporating patients’ insights to improve services.
"We were really pleased to officially open the new Ophthalmology Treatment Room at University Hospital. Our partnership with Novartis allowed us to buy new equipment and renovate the room. It means that we can now offer patients treatment for retinal eye conditions in Coventry as well as Rugby, improving access for patients across our area."
NHS Wales is working with Novartis on an joint working project aimed at improving outcomes for patients with heart failure and lung cancer. The project has brought together the unique expertise, experience and perspectives from the NHS and from Novartis to identify areas where performance is sub –optimal and to design interventions that are both innovative and practical. We have drawn distinctive input from many Novartis colleagues and have had access to external support from Novartis’ partners. Novartis have shown a genuine willingness to engage meaningfully with both clinical and managerial colleagues in support of the project’s objectives.
When a pharmaceutical company works on projects in partnership with the National Health Service (NHS), this is normally known as ‘joint working’. See here for a full listing of our Joint Working agreements.